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Abstract
The second International Symposium on Animal Genomics for Animal Health held in Paris, France 31 May-2 June,
2010, assembled more than 140 participants representing research organizations from 40 countries. The symposium
included a roundtable discussion on critical needs, challenges and opportunities, and a forward look at the
potential applications of animal genomics in animal health research. The aim of the roundtable discussion was to
foster a dialogue between scientists working at the cutting edge of animal genomics research and animal health
scientists. Importantly, stakeholders were included to provide input on priorities and the potential value of animal
genomics to the animal health community. In an effort to facilitate the roundtable discussion, the organizers
identified four priority areas to advance the use of genome-enabled technologies in animal health research.
Contributions were obtained through open discussions and a questionnaire distributed at the start of the
symposium. This report provides the outcome of the roundtable discussion for each of the four priority areas. For
each priority, problems are identified, including potential solutions and recommendations. This report captures key
points made by symposium participants during the roundtable discussion and serves as a roadmap to steer future
research priorities in animal genomics research.
Background
One of the primary aims of the second International
Symposium on Animal Genomics for Animal Health
(AGAH) was to explore advances made since the first
symposium [1] and to update the recommendations
made in 2007 for integrating genome-enabled technolo-
gies in animal health research [2]. To achieve this aim, a
roundtable discussion of leading experts in the field of
genomics and animal health was organized. With contri-
butions from the symposium participants through open
discussions and a questionnaire distributed at the start
of the symposium, four priorities were identified that
are likely to have the greatest impact on animal health
research. This report captures the problems to be solved
within the four priority areas and provides potential
solutions and recommendations.
1. Marker-assisted Selection of Animals with Desirable
Health Traits
2. Functional Genomics of Host-Pathogen Interactions
3. Translating Genomic Information to Tools for Con-
trolling Diseases
4. Integrating Stakeholder Support to Advance Animal
Genomics in Animal Health
Marker-assisted selection of animals with
desirable health traits
Genetic studies which aim to quantify between-host var-
iation in health-related traits or are intended to identify
genetic markers associated with health have the poten-
tial to impact on many areas of disease control. How-
ever, it is only in recent years that these opportunities
are beginning to be recognized by both the veterinary
and animal genetics communities. Undoubtedly, it is the
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the availability of dense single nucleotide polymorphism
(SNP) arrays in every major livestock species coupled
with the prospect of resequencing large chunks of ani-
mal genomes, which have focused the attention of
diverse research communities on the opportunities at
hand. However, other factors have also come into play.
T h e s ei n c l u d en o t a b l es u c c e s si nt h eh u m a ng e n e t i c s
community in mapping genes controlling variation in
complex diseases, the maturing of several large quantita-
tive genetic studies investigating resistance to infectious
diseases in livestock populations, and the demonstration
that even field data beset by considerable noise and
imprecision can still contain valuable information on
host genetic variation. However, it remains true that
quantitative genetic studies to identify heritable health
traits and genetic marker associations are difficult and
expensive. Phenotype acquisition has become the major
bottleneck, with genomic information now no longer
being the rate limiting step.
One of the outcomes of the AGAH symposium is the
agreement that there are no generic solutions for sol-
ving the problems associated with quantitative genetic
and genetic marker studies. The solutions depend
upon the biology of the host animal, which generally
determines the structure of the industry. Further, the
industry structure influences both the nature of the
predominant health problems encountered and the
ease of data capture. The rapid and sustained develop-
ment of genome-enabled technologies of the last few
years, especially genotyping and sequencing, has pro-
vided extraordinary opportunities for advancing this
field of research, however other issues remain. Partici-
pants overwhelmingly agreed that a key challenge
remains the difficulty in acquiring and validating ani-
mal phenotypes. Critical needs include standardized
protocols for collecting tissues and phenotypes for dis-
ease resistance traits in both experimental resource
and relevant commercial animal populations. Addition-
ally, a need was seen and agreed for proof-of-concept
studies for marker-assisted selection (for disease resis-
tance or improved health) in prioritized species. This
was seen as being enhanced by multidisciplinary stu-
dies. Lastly, user-friendly and cost-effective delivery of
marker-assisted selection was raised as an issue, parti-
cularly in developing countries.
Problems to be solved
1. Availability of appropriate and reliable phenotypes,
including health records
a. Problem: The rate limiting step in studies aiming to
detect genetic markers for health is invariably the collec-
tion of phenotypes, rather than genotypes. This is a gen-
eral problem in many genomic studies, including studies
on non-disease traits, and is known generically as the
‘phenotype gap’. However, the situation is exacerbated
for disease traits as phenotypes of disease susceptibility/
resistance to infectious diseases are often more difficult
and/or expensive to measure than those for performance
traits. Their measurement usually requires the involve-
ment of infection, either deliberate or through clinical
history of naturally infected animals.
Various scenarios may be envisaged, and the data col-
lection strategies will vary according to the scenario. For
example, with many endemic diseases, animals may face
natural challenge under field conditions. In contrast,
with epidemic diseases, data collection opportunities
from disease outbreaks may only be sporadic, otherwise
deliberate challenge experiments may be needed.
Further, some diseases are multifactorial. For example,
mastitis may be caused by many pathogens, and the
pathogenesis resulting from these specific infections
may differ dramatically. Therefore, an important issue is
whether it is possible to have generic solutions to multi-
factorial diseases or, conversely, pathogen-specific solu-
tions are required – invoking considerable extract com-
plexity in data recording.
In many cases, disease outcomes may be the result of
infection coinciding with stress induced immune sup-
pression in livestock. An example is the respiratory dis-
eases of livestock and poultry in intensive animal
production systems caused by several different patho-
gens (viral and/or bacterial) in association with trans-
port, co-mingling of pooled animals, dietary changes
and administration of various veterinary treatments.
Mastitis is another example of a disease where clinical
cases often have an underlying issue of immune sup-
pression in early lactation. In such cases, addressing ani-
mals’ ability to cope with stress may be as effective as
concentrating on animals’ resistance to infection.
Related to the issue of stress is that of robustness. Of
particular interest to breeding companies is the ability
to breed animals that are robust across a variety of
environments and infectious challenge conditions. This
is particularly important when there are few pathogens
or diseases that can be identified as overwhelming can-
didates for marker-assisted selection, yet general health
issues are perceived. Many approaches have been advo-
cated for addressing this issue, including interrogation
of detailed health records, using animal performance as
a proxy for health, and attempting to identify underlying
immunological correlates of robustness.
b. Potential solutions: Solutions and recommendations
invariably involve large scale, multidisciplinary, some-
times multi-national, projects which ‘think big’, i.e. max-
imize the use of animal resources and human expertise.
In particular, it is critical that dialogue is established or
strengthened between contributors with complementary
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and other relevant disciplines.
Researchers should also be aware that opportunities to
record phenotypes may occur in populations that are
not standard commercial populations or well-character-
ized experimental lines. For example, livestock exposed
to extremes of environment or disease, especially in
developing countries, may be a rich reservoir of traits
and gene variants related to health issues.
T h eg o a ls h o u l db et om o v et o w a r dm o r e“proactive”
sample collection, with specific recommendations on
optimum timing and handling of blood (or other tissue)
sample collection for a wide array of immunological and
other disease-related studies. The now widespread avail-
ability of high-throughput technologies, including dense
SNP chips for nearly all livestock species, is particularly
advantageous. They allow creation of animal pedigrees,
i.e. accurate estimation of genetic relatedness between
individuals, and they enable quick and efficient genome
scans for markers in LD with causative mutations. How-
ever, care needs to be taken with population genetic
structure – mixed breed populations are likely to lead to
spurious results unless sample sizes are very large and
very dense SNP chips are available.
For predictable widespread diseases, international
agreement is required for measurement protocols for
predictable diseases. Extensive data requires that they be
collected and stored on accessible databases. For emer-
ging diseases, dialogue with governmental and other ani-
mal health policy makers to ensure timely capture of
epidemic outcome data, for use in population-level
quantitative genetic or epidemiological analyses. Includ-
ing data collected on health traits in animal disease stu-
dies conducted in controlled laboratory settings, where
the experiments are sufficiently large to provide mean-
ingful data, will reduce the complication of uncontrolled
environmental factors.
For general health issues, further research into the
best means of describing host genetic effects is required.
Support research to define heath traits at the molecular
level. Narrowly defined phenotypes can significantly
increase the power of detecting genetic factors involved
in disease susceptibility and disease resistance, however
they make phenotype collection more challenging.
Research into the identification of animals with superior
ability to withstand the immunosuppressive effects of
stress may open new opportunities.
2. Development and availability of genome-associated
research tools
a. Problem:D e n s eS N Pc h i p s ,u s u a l l yc a .5 0 kS N P s ,
are now available for nearly all livestock species. Whilst
this is a luxury almost undreamt of a few years ago,
these tools remain somewhat paradoxical. They are still
considered too sparse for fine mapping of causal muta-
tions, or for studies that extend across breeds or com-
prise genetically sub-structured populations, yet they are
still expensive for routine use. SNP chips with several
hundreds of thousands of markers will be more flexible,
albeit expensive. However, even these are likely to have
some limitations, for example incomplete LD with cau-
sative mutations at low frequencies (i.e. <0.1); it is muta-
tions at low frequencies which may well have larger
effects on the phenotype.
A significant issue with animal genome sequences is
the lack of annotation, which is mostly based on homol-
ogy to other genes and not actual experimental testing
in the species of interest.
b. Potential solution: Dense SNP chips will be required
for all species. However, in parallel, sparse SNP chips to
be used for imputation of haplotypes will be required to
reduce the cost of utilization of SNP chips for the pur-
pose of genome-wide selection.
The big challenge, and the big opportunity, now lies
in obtaining and interpreting sequence data for popu-
lations of animals. Individual genome sequences offer
unparalleled opportunities for identification of causa-
tive mutations, for the generation of SNPs to be used
in population-wide studies, for identification of animals
with superior genotypes and for gaining additional
understanding of the genetic control of traits of
interest.
T h es a m eh i g ht h r o u g h p u tt echnologies that enable
large scale genotyping and sequencing will also enable
great insight into transcriptomics, through sequencing
of transcripts. This, along with technologies that mea-
sure protein (protein arrays or mass spec) and metabo-
lites will allow greater insight and contribute to genome
annotation.
Continued efforts in genome sequencing and SNP dis-
covery are needed. Formation of large international con-
sortia is required to reduce per-unit cost of using SNP
chips. Both high density arrays, for mapping of causal
mutations, and low density arrays for haplotype imputa-
tion are required. There is also a need to support other
high throughput technologies such as DNA chips and
protein arrays.
3. Refining quantitative population genetic studies to
usable markers
a. Problem: The step from discovery of significant
marker associations to utilizable markers for animal
health can be long, difficult and expensive.
b. Potential solutions:T h es o l u t i o n sd e p e n du p o nt h e
nature of the phenotype and the architecture of host
genetic resistance, i.e. whether the genetic variation is
due to a small number of polymorphisms with large
effects, or whether it tends to be under polygenic control.
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gle genes dominate host genetic variation, a usable mar-
ker(s) must be found. A SNP-based genome scan alone
is unlikely to be sufficient, and information must be
used from other sources (‘screening filters’), including
comparative genomics, functional genomic studies and
verification in independent animals. Once a region on
the genome is found, one should (1) refine the position
using more markers, (2) confirm the association in inde-
pendent animals, and (3) when possible, sequence as
many animals as possible for novel genetic variants.
Where genetic control is polygenic, and phenotypes
are readily obtained on large numbers of animals, it is
not necessary or even useful to resolve the genetic mar-
ker to a causative mutation or tightly linked marker –
in this case ‘genome-wide selection’ can be used. The
s u mo fa l lS N Pe f f e c t sa c r o s st h eg e n o m ec a nb eu s e d
to predict next generation performance/resistance/health
status. However, in this situation costs that are incurred
on a routine basis are likely to be high, thus strategic
use of sparse SNP chips for imputing haplotypes is likely
to substantially reduce costs.
Recommendations
￿ Support research to define health traits at the molecu-
lar level with the aim of detecting genetic factors
involved in disease susceptibility and disease resistance
￿ Support initiatives at every level (national, regional,
private, research project) that aim to proactively record
defined health traits and collect samples from either
commercial populations, well-characterized experimental
animal lines, or where livestock and poultry are exposed
to extremes of environment or epizootics
￿ Support the development of inter-operable databases
for large-scale storage of pedigree information, pheno-
types, and associated environmental factors
￿ Support national and international efforts that aim
to sequence animal genomes, develop genome-enabled
technologies, and enable their cost-effective use in
research
￿ Support the building and integration of bioinfor-
matics infrastructures in animal health research institu-
tions, including the development of statistical models
and software for animal genomics research
￿ Support research programs that focus on the the
selection of animals with superior resistance to the
immunosuppressive effects of stress
￿ Support large-scale coordinated research programs
a i m e da te l u c i d a t i n gr e l e v a nt aspects of host-pathogen
interactions for high priority diseases
￿ Support meetings and workshops to enhance com-
munication and facilitate collaborations between quanti-
tative geneticists and experts in animal health
Functional genomics of host-pathogen
interactions
New research strategies employing high-throughput
gene expression analysis are providing novel platforms
for more comprehensive understanding of host–patho-
gen interactions. In particular, functional genomics is
rapidly revolutionizing the analysis of whole genome
responses of the host to environmental, nutritional, or
disease factors that affect the health of animals. The
symposium included several presentations on gene
expression and functional genomics studies that had
the aim of looking for genes that were differentially
expressed. The symposium participants overwhel-
mingly expressed the importance of basic research and
the inclusion of genome-enabled technologies in ani-
mal health research. Many of the questions and com-
ments from the audience pointed out that the
causative polymorphisms may reside on completely dif-
ferent chromosomes from the genes that are differen-
tially expressed and the importance of considering
epigenetic effects.
Problems to be solved
1. Availability of validated animal disease models
a. Problem: There is a critical need to develop animal
disease models that mimic field infections using statisti-
cally significant number of animals per group and stan-
dardized challenge inoculums. Also critical is the need
to share challenge inoculums from a single source to
reduce experimental variations.
There is also a major need to get better sampling tools
and methods to handle and store them for multiple pro-
tein and nucleotide analyses; e.g., protocols for handling
blood, saliva and oral fluids, nasal, vaginal and other
easily accessible mucosal samples, urine and fecal
samples.
b. Potential solutions: Define validated disease chal-
lenge models with respect to challenge dose, challenge
inoculum that are similar to the field situation with
respect to virulence and pathogen genomic sequence,
and designate resource centers specialized in given dis-
ease models to share information through public
websites.
2. Animals with defined disease susceptible/disease
resistant phenotypes
a. Problem: There is a lack of livestock and poultry
breeds with well characterized genotypes and disease
phenotypes whose variations can be correlated with
innate and acquired immune status of the host.
b. Potential solutions:
￿ Identify disease phenotypes important to industry
and determine how host and pathogen genetic poly-
m o r p h i s m ss u c ha sS N P si n f l u e n c et h eo u t c o m eo f
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phenotypes.
￿ Increase the genetic analysis of animals with charac-
terized animal phenotypes in challenge experiments to
build SNP maps that define the influence of genetic
polymorphisms on host immune response to pathogens.
3. Bioinformatics tools
a. Problem: Animal health research laboratories lack
bioinformatics infrastructure: computer hardware, soft-
ware, and trained scientists in computational biology.
There is also a lack of animal and pathogen species-spe-
cific genomics and proteomic tools with well-annotated
genome databases to predict key immunogenic epitopes
in the context of different target species to understand
the triggering mechanisms of the protective immune
response and to evaluate vaccine-induced immunity for
the animal health research community.
b. Potential solutions:
￿ Train animal health scientists in computational
biology
￿ Build bioinformatics infrastructure within animal
health research centers
￿ Build international animal genome databases
￿ Utilize available genomics resources developed in
mouse and human systems, and build comparison maps
for immune system genes in the target animal species
￿ Align international consortia with the aim of build-
ing animal genome databases as well as genome data-
bases for important classes of animal pathogens.
4. Identification of genes that are involved in the acti-
vation/repression of key regulatory pathways
a. Problem: There is a need to identify molecular path-
ways of host and pathogens that are involved in trans-
mission, survival, virulence, innate and adaptive immune
responses, and protective immune response to natural
infection and vaccination. The ultimate goal is the need
to identify the “operational limits” in the genomic
“imbalance” associated with current genetic selection.
Basic studies are needed to enhance our understanding
of the complexities of gene regulation and expression
pathways, determining how species and individual
genetic variations influence essential gene expression
pathway and alter protein interactions. It is essential to
identify where anti–pathogen responses diverge to iden-
tify pathogen specific targets.
b. Potential solutions:
￿ We need a more comprehensive approach for using
functional genomics to lead us to polymorphisms that
will be useful for predicting genetic merit for animal
health traits. One potential approach is to use QTL stu-
dies to identify small sets of animals that are expected
to differ only in whether they have favorable or unfavor-
able genotypes at the QTL. Use highly parallel gene
expression technology (RNA-seq, microarrays or SAGE)
to determine differences in expression in relevant tissue
samples that are due to the QTL. Develop RT-PCR or
other similar assays for the transcripts that are most
highly related to QTL genotype in the small sample.
Run these RT-PCR assays on the entire QTL population
and redo the QTL scan. The expression data are
expected to be much higher in heritability, and there-
fore, a much better data set for QTL detection, than
direct disease data. This QTL scan should provide much
better information for locating the position of the QTL
and establishing relationships between haplotypes and
disease resistance that should hold up across multiple
breeds.
￿ Develop genome-wide high throughput transcrip-
tional profiling systems to study host-pathogen interac-
tions and identify key candidate host and microbial
genes that are associated with infection, pathogenicity,
antigenic variation and host range specificity.
￿ Invest more resources and time into the interac-
tomics and metabolomics area.
5. Development and availability of reagents to study
gene function
a. Problem: There is a need to develop a full set of
specific research reagents for the key gene products
involved in immune functions. Pathways identified for
human and mouse species may not be applicable to
food animal species. There is a need to develop species
specific information. This requires basic set of species
specific reagents, databases to track homologies and
differences.
b. Potential solutions:
￿ Identify research centers with capability to develop
immune reagents and specific knock-out tools (e.g.,
siRNAs).
￿ Expand existing research projects on the develop-
ment of immunological reagents for different animal
species.
6. Discovery of biomarkers
a. Problem: It is paramount that the animal health
research community has access to measurable biomar-
kers linked to disease susceptibility, disease resistance,
and mechanisms of protective immunity. There is still a
major need to get better sampling tools and methods to
handle and store samples for multiple analyses, e.g.,
transcriptome, proteome, metabolome, and protocols for
handling blood, saliva and oral fluids, nasal, vaginal and
other easily accessible mucosal samples, urine and fecal
samples. There is also a need to identify biomarkers for
healthy animals, whether that be better responders to
pathogens or to vaccinations. Final outcome could be an
animal that responds more favorably with its innate
immune response. However, it is important that selec-
tion for “robust animal” excludes the selection for non-
desirable traits. Important factors for each species must
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selection process.
b. Potential solutions:
￿ Conduct biomarker discovery studies with “standar-
dized” validated animal models that have well defined
phenotypes.
￿ Increase the use of proteomics and transcritomic
technologies in biomarker discovery studies and imple-
ment the rational use of proteomics data to develop spe-
cific biochips/protein chips for genomics research.
￿ Identify techniques to effectively assess phenotype at
multiple stages of host –pathogen interaction: infectious
course, disease pathology, recovery and persistence.
These must be robust to address current commercial
stock as well as genetics relevant to small farms and
developing economies.
Recommendations
￿ Support the development of experimental animal chal-
lenge models that provide measurable phenotypes rele-
vant to actual diseases under field conditions
￿ Support long-term projects that will build the infra-
structure needed to conduct the extensive phenotyping
and genotyping of animal populations relevant to animal
health priorities
￿ Support research programs that aim to identify
genetic markers that correlate with disease phenotypes,
and carry out whole genome expression analyses using
tissue-specific microarrays and RNA-seq to identify gen-
ome sequences that influence disease parameters
￿ Support functional genomics research programs that
aim to identify genetic markers that are linked to regula-
tory pathways that modulate host-pathogen interactions
￿ Support research programs in relevant animal hosts
that aim to confirm the association of genetic markers
with host responses in large animal populations
￿ Support the establishment of core bioinformatics
infrastructures with state-of-the-art genomic tools and
resources that can integrate genotype, phenotype and
functional genomics data for agricultural animal species
and their respective priority diseases
￿ Support genome database initiatives for priority ani-
mal species and pathogens
￿ Develop proteomics tools to support animal health
research projects that have the aim of identifying host
molecules and biomarkers that are associated with or
have a role in modulating host-pathogen interactions
￿ Establish an international consortium to advance and
enable the development of reagents to study gene regu-
lation, gene function, and disease pathways in priority
animal species
￿ Support initiatives to integrate genetic, functional
genomics, and bioinformatics data in a systems biology
approach to understand complex diseases
￿ Organize & manage all interactome research efforts
using the technology readiness level standard for
improving the efficiency of moving from concept to
reduction to practice for direct application in the animal
production systems.
￿ Create, test & validate comprehensive predictive
biology models for optimizing animal health in the
prioritized pathogens in the prioritized livestock species.
Translating genomic information to tools for
controlling diseases
Genomic tools are providing new opportunities for
understanding genetic diversity, the genetic variation
associated with diseases processes, and host-pathogen
interactions. The scientific information generated from
the use of these tools in animal health research will
enable the rational design of highly effective diagnostics,
vaccines, drugs, biotherapeutics, and animals resistant to
diseases.
Problems to be solved
1. Using animal genomes to understand genetic diversity
and inform best management practices to improve ani-
mal health and animal production systems.
a. Problem: There is a critical need to preserve animal
genetic diversity and to understand the role of genetic
variations on host responses to diseases, drug treat-
ments, and vaccination.
b. Potential solutions:
￿ U s eg e n o m ew i d eg e n e t i cm a r k e r sa n dn o v e lm e t h -
ods to actively manage animal biodiversity
￿ Study the dynamics of specific and general response
to disease challenges, especially innate immunity.
￿ Evaluate animal disease models that try and replicate
“real world” disease complexes, such as the polymicro-
bial infections associated with the bovine respiratory dis-
ease complex.
￿ Establish general guidelines for using genomic tools
in drug and vaccine clinical trials to identify the geno-
type of study animals and their response to the chal-
lenge and/or test treatment.
2. Easy to use diagnostic platforms for genetic tests,
forensic veterinary medicine and traceability.
a. Problem:T h e r ei sal a c ko fr a p i d ,r o b u s t ,a c c u r a t e
and cost effective genetic tests to use in analyzing dis-
ease outbreaks for both the disease agent and the host.
b. Potential solutions:
￿ Develop molecular diagnostics for genotyping hosts
and pathogens
￿ Develop diagnostic platforms to predict new and
emerging high-virulence pathogenic strains and the
expected susceptible animal populations
￿ Develop molecular diagnostics to facilitate the trace-
ability of animals with desired or undesired health traits
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resistant traits
a. Problem: There is a need to integrate studies on dis-
ease resistance with selection programs. This will
require strategic collaborations with commercial breed-
ing companies.
b. Potential solutions:
￿ Establish collaborations from an early stage using
animals in well structured populations with good
records and already well characterized phenotypes.
￿ Animal challenge models must be commercially rea-
listic and include polymicrobial /combined disease
challenges.
￿ Establish correlated responses to selection for any
marker.
4. Application of genome-enabled technologies in drug
and vaccine discovery, including transgenic animals that
are resistant to disease and the selection of animals that
respond effectively to drugs and vaccines.
a. Problem: The application of animal genome-enabled
tools will demand fundamental changes in the
approaches used to discover and develop animal drugs
and vaccines, including their delivery and application in
disease control programs. One of the main challenges is
the total absence of regulatory guidelines for the appli-
cations of these new technologies, including transgenic
animals. The ability to design drugs and vaccines for
genetically defined animal populations will require addi-
tional planning. For instance, in the area of vaccines,
there is lack of established “vaccine profiles” to identify
specifically what a vaccine is expected to achieve (e.g.,
efficacy with one dose, mass vaccination capability, pre-
vent disease transmission, etc) for specific diseases in
individual animals and targeted commercial populations.
Vaccines must not only be designed to achieve the
desired vaccine profile but must also anticipate the
genetic variations of the host and pathogens to enable
predicted outcomes in vaccination campaigns and the
selection of good responders to vaccination.
b. Potential solutions:
￿ Support vaccine discovery research programs that
target vaccines specifically designed for control and
eradication.
￿ Support vaccine studies that assess new pathogenic
strains, especially ‘escapes’ from vaccine protection.
￿ Integrate genomic tools in drug and vaccine studies
to assess the effects of genetic variation on efficacy and
the control of disease in defined animal populations.
￿ Support vaccine studies that take into account age
dependent effects of vaccines and adjuvants with
maturation of the immune system.
￿ Support research programs that integrate genomic
and transgenic technologies to achieve disease resistance
￿ Include regulatory agencies in the early phases of
research programs that integrate genome-enabled tools
in study designs
￿ Establish strategic research collaborations with com-
mercial breeding companies and pharmaceutical
companies.
Recommendations
￿ Support initiatives that will use animal genomic inno-
vations to assess and manage domestic and wildlife ani-
mal genetic diversity
￿ Support studies that will lead to the development of
rapid, accurate and cost-effective molecular genetic tests
for host and pathogens to analyze field disease outbreaks
and to develop predictive diagnostics
￿ Integrate disease resistance traits with existing multi-
trait selection programs
￿ Integrate genetic profiling in the development of dis-
ease models for drug and vaccine discovery research
￿ Support initiatives that integrate genomic
approaches to vaccine development, including genetic
and immune variations in target animal populations
￿ Support transgenic animal research programs that
target disease resistance
￿ Support research programs that include collabora-
tions between animal health research institutions, com-
mercial breeding companies, and pharmaceutical
companies
Integrating stakeholder support to advance
animal genomics in animal health
The promise of animal genomics will not be achieved
without stakeholder support. The burden of communi-
cating the significant opportunities that genome-enabled
technologies offer for improving animal health lies
squarely on the shoulders of the animal health research
community.
Problems to be solved
1. Collaborations between the public and private sectors
a. Problem: Animal health is a very broad area with
different diseases affecting different sectors, species, and
regions. There is a lack of understanding of the oppor-
tunities for new approaches and in particular what is
required for progress. There is a critical dearth of fund-
ing for animal health research and bias against non-
hypothesis led approaches.
b. Potential solutions:
￿ Establish priorities for research – specific diseases,
general “robustness.”
￿ Establish funding mechanisms that enable research-
ers to work with producers and provide access to large
numbers of relevant animals.
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level including “SWAT teams” to collect phenotypic
information and appropriate samples (including environ-
mental data).
2. Intellectual property and technology transfer to
industry
a. Problem: Too many groups involved in “protecting”
IP before any is developed, inhibiting cooperation or
blocking progress. Adversarial approaches to protection
predominate. Suspicion of need for profitable applica-
tion. Possible competition between genetic and
“pharma” approaches reducing investment.
b. Potential solutions: Seek to develop approaches
based on pre-competitive research.
Seek an “open” shared approach to generating “next
generation” IP. Create “incubator” opportunities to take
results to application.
3. Impact on veterinary education and animal and
poultry science
a. Problem: Little dialogue between veterinarians and
animal and poultry science particularly in relation to the
genetics of animal health. The focus tends to be on dis-
ease challenge or in vitro approaches with limited num-
bers of animals or genetic variation.
b. Potential solutions:
￿ Seek to stimulate multidisciplinary teaching across
schools.
￿ Seek to stimulate joint research across disciplines.
￿ Seek to stimulate “host-centered” approaches.
4. Contributions of veterinary practitioners, animal
health professionals, and animal agriculture allied
industries
a. Problem: There is a lack of a unified vision on the
opportunity of genomics for animal health; a lack of
understanding of actions required to investigate the
genetics of animal health; and poor definition of new
tools required to undertake the required research.
b. Potential solutions:
￿ Develop a strategic vision for animal genomics for
animal health setting out the roles of each group of
industry professionals.
￿ Create a communication program to stimulate inter-
est of, and dialogue between, these groups.
￿ Focus on solutions that work at the population level.
5. Support from regulatory agencies to enable these
new technologies
a. Problem: Regulatory environment for “gene-based”
t e c h n o l o g i e s ,e . g .G e n e t i cM o d i f i c a t i o n ,C l o n i n g ,R N A
interference, DNA vaccination, is unclear and inhibits
research (as well as commercialization).
b. Potential solutions:
￿ Develop science-based approach to “technical”
aspects of regulation.
￿ Utilize “participatory” approaches to stimulating
public debate and informing the regulatory process.
￿ Develop a regulatory system to deal with issues of
public acceptability in parallel with the technical aspects.
￿ Benchmark other industries in relation to “licensing”
of new and/or advanced technology.
Recommendations
￿ Support the funding of innovations in animal geno-
mics research specifically designed to solve problems in
animal health
￿ Develop integrated approaches that include the
development of sample repositories and databases that
support research networks
￿ Develop more “epidemiological” approaches to the
genetics of animal health and integrate in veterinary and
animal science educational programs
￿ Establish and support demonstration projects to
deliver concrete examples of the value of integrating
genome-enabled technologies in animal health research
programs
￿ Establish a progressive international regulatory fra-
mework that is science-based and provides a clear path
for registering animal disease control tools derived from
genome-enabled technologies
￿ Support meetings to align veterinarians, animal
scientists, and genomics/genetics experts to foster a dia-
logue and educate on the importance of multidisciplin-
ary approaches addressing the application of genome-
enabled technologies to animal health
Conclusion
The availability of new animal genomics tools provide
extraordinary opportunities for solving some of the
most pressing and difficult problems in animal health
research. Animal genomics also provides new innova-
tive approaches for controlling diseases affecting
domestic animals. Quantitative genetics, functional
genomics, translating genomics information into tools
for controlling diseases, and integrating stakeholder
support were identified as four priority areas for ani-
mal health research. Investing in basic research was
also identified as critical for the sustainability and suc-
cess of animal genomics research in animal health.
The application of new genome-enabled technologies
in animal health research has the potential of signifi-
cantly improving the health and welfare of animals,
resulting in improved efficiency, sustainability, biose-
curity, and the protection of animals worldwide. This
report provides a roadmap for moving forward by pro-
viding recommendations and concrete steps to achieve
the impact that animal genomics offers animal health
research.
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